The Path to Innovation in Rare Diseases comes through Partnerships – A reflection on the EU Pharmaceutical Package

Rare Disease Day 2023: A Shared Vision for the EU Rare Disease Ecosystem

World Cancer Day 2023: Fostering the EU Advanced Diagnostics Ecosystem to tackle the Cancer Burden

Launch Conditionality: What’s at stake?

From the EUCOPE Blog archives

The increasing importance of Real World Evidence (RWE) and the need for a multi-stakeholder approach

October 27, 2022

What is Needed to Reinforce Biopharmaceutical Innovation in Europe?

October 12, 2022

The European Health Data Space (EHDS): How will it impact health technology companies operating in or about to enter the EU?

September 19, 2022

GUEST: What’s on the horizon for life sciences and health care?

June 30, 2022

Five Priorities for a Successful EU HTA Procedure

April 27, 2022

To the archives